GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » EPS (Basic)

U-Neuron Biomedical (ROCO:6973) EPS (Basic) : NT$-3.54 (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical EPS (Basic)?

U-Neuron Biomedical's basic earnings per share (Basic EPS) for the six months ended in Dec. 2023 was NT$-0.92. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-3.54.

U-Neuron Biomedical's EPS (Diluted) for the six months ended in Dec. 2023 was NT$-0.92. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-3.54.

U-Neuron Biomedical's EPS without NRI for the six months ended in Dec. 2023 was NT$-0.92. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -3.54.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


U-Neuron Biomedical EPS (Basic) Historical Data

The historical data trend for U-Neuron Biomedical's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical EPS (Basic) Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EPS (Basic)
- -0.93 -2.70 -3.21

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
EPS (Basic) - -1.06 -1.64 -2.63 -0.92

U-Neuron Biomedical EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

U-Neuron Biomedical's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-84.891-0)/26.462
=-3.21

U-Neuron Biomedical's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-28.822-0)/31.503
=-0.91

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-3.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


U-Neuron Biomedical  (ROCO:6973) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


U-Neuron Biomedical EPS (Basic) Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


U-Neuron Biomedical (ROCO:6973) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines